Aptamino
The Oral Antibody Company
Cambridge, United States · $8.0M raised
- Headquarters
- Cambridge, Massachusetts
- Employees
- 1–10
- Business Model
- B2B
- Total Funding
- $8.0M
- Last Round
- $8.0M SeedApr 2026
- Rounds
- 1
About
Aptamino is a seed-stage biotechnology company developing oral antibody therapeutics. Operating in stealth mode, the company is focused on engineering antibody structures that can be delivered orally rather than via injection, addressing a significant challenge in protein drug delivery. Aptamino is headquartered in Cambridge, Massachusetts, and has filed patents on coiled coil immunoglobulin fusion proteins and antibody-IL2 engrafted proteins for cancer treatment applications. The company is in early-stage research and has been recruiting protein science researchers to build out its discovery capabilities.
Summary
Aptamino is a Biotech company based in Cambridge, United States. It has raised $8.0M in total across 1 round, most recently a $8.0M Seed round in Apr 2026. Investors include Freestyle Capital, Modi Ventures and Spacecadet Ventures.
Funding History
Apr 2026
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Simtra provides pharmaceutical and biotech clients development and manufacturing services for ste...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/aptamino"><img src="https://indexed.vc/api/badge/company/aptamino" alt="Aptamino on Indexed.vc" width="260" height="76" /></a>